PDE11A defects have been linked to several cancers (adrenal, testicular, and prostate) and to major depression, bipolar disorder, and asthma, implicating specific PDE11A inhibitors as potential drug targets (41). This evidence concerns the gene PDE11A and major depressive disorder.